Index Venture Associates III Ltd

CIK 1503683 · last filed 2019-06-19

Index Venture Associates III Ltd is a corporate insider who has filed 7 SEC Form 4 insider transactions across 2 companies since 2011. The most recent filing shows the insider sold $1.9M of NERV on Jun 19, 2019. Across all open-market trades the lifetime net is −$74.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $2.1M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$2.15M

Companies

2

Total Filings

7

Lifetime Open-Market Net

-$74.25M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
NERV	10%+ Owner	532,085	$4.04	$2.15M	-$7.45M	5	2019-06-19
Aegerion Pharmaceuticals, Inc. (AEGR) Delisted	10%+ Owner	2,131,827	—	—	-$66.80M	2	2011-08-02

Recent Filings

7 filings

Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.

Filed	Symbol	Action	Net Shares	Net $	Link
2019-06-19	NERV	Sell (S)	−423,672	-$1.88M	EDGAR
2019-06-13	NERV	Sell (S)	−240,204	-$1.13M	EDGAR
2018-10-01	NERV	Sell (S)	−265,092	-$3.34M	EDGAR
2016-08-12	NERV	Sell (S)	−4,000,000	-$40.00M	EDGAR
2014-07-09	NERV	Mixed	+7,187,328	$43.12M	EDGAR
2011-08-02	Aegerion Pharmaceuticals, Inc. (AEGR) Delisted	Sell (S)	−183,940	-$2.69M	EDGAR
2011-07-01	Aegerion Pharmaceuticals, Inc. (AEGR) Delisted	Sell (S)	−4,388,615	-$64.11M	EDGAR

Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.